Global Information
회사소개 | 문의 | 비교리스트

세계의 점막하 주입제 시장 : 분석과 예측(2017-2028년)

Global Submucosal Injection Agent Market Report, History and Forecast 2017-2028

리서치사 QYResearch
발행일 2022년 07월 상품코드 1104946
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
가격
US $ 3,350 ₩ 4,390,000 PDF (Single User License)
US $ 5,025 ₩ 6,585,000 PDF (Multi User License)
US $ 6,700 ₩ 8,780,000 PDF (Enterprise User License)


세계의 점막하 주입제 시장 : 분석과 예측(2017-2028년) Global Submucosal Injection Agent Market Report, History and Forecast 2017-2028
발행일 : 2022년 07월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

COVID-19 팬데믹에 의해 점막하 주입제 세계 시장 규모는 2021년에 9,535만 달러 규모로 평가되었고, 2028년에는 1억 5,976만 달러에 이르며, 예측 기간(2022-2028년)에는 7.65%의 연평균 복합 성장률(CAGR)이 예측됩니다.

목차

제1장 점막하 주입제 : 시장 개요

  • 점막하 주입제 : 제품 개요
  • 유형별 시장 부문
    • 시린지형
    • 앰플형
  • 유형별 시장 규모
    • 시장 규모 개요 : 유형별(2017-2028년)
    • 과거 시장 규모 : 유형별(2017-2022년)
    • 시장 규모 예측 : 유형별(2023-2028년)
  • 주요 지역 시장 규모 : 유형별
    • 북미의 점막하 주입제 판매 : 유형별(2017-2022년)
    • 유럽의 점막하 주입제 판매 : 유형별(2017-2022년)
    • 아시아태평양의 점막하 주입제 판매 : 유형별(2017-2022년)
    • 라틴아메리카의 점막하 주입제 판매 : 유형별(2017-2022년)
    • 중동 및 아프리카의 점막하 주입제 판매 : 유형별(2017-2022년)

제2장 점막하 주입제 : 기업별 시장 경쟁

  • 세계 점막하 주입제 주요 기업의 판매(2020년-2022년)
  • 세계 점막하 주입제 주요 기업의 매출(2020년-2022년)
  • 세계 점막하 주입제 주요 기업의 가격(2020년-2022년)
  • 세계 점막하 주입제 주요 제조업체의 제조거점 및 판매 지역
  • 점막하 주입제 시장의 경쟁 상황과 동향
  • 세계의 주요 제조업체 : 기업 유형별(Tier 1, Tier 2, Tier 3)(매출별, 2021년)
  • 주요 제조업체의 주력 제품

제3장 점막하 주입제 : 지역별 현황과 전망

  • 세계의 점막하 주입제 시장 규모·CAGR : 지역별(2017년/2021년/2028년)
  • 과거 시장 규모 : 지역별
  • 시장 규모 예측 : 지역별

제4장 점막하 주입제 : 용도별

  • 용도별 시장 규모
    • 시장 규모 개요 : 용도별(2017-2028년)
    • 과거 시장 규모 : 용도별(2017-2022년)
    • 시장 규모 예측 : 용도별(2023-2028년)
  • 주요 지역 시장 규모 : 용도별
    • 북미의 점막하 주입제 판매 : 용도별(2017-2022년)
    • 유럽의 점막하 주입제 판매 : 용도별(2017-2022년)
    • 아시아태평양의 점막하 주입제 판매 : 용도별(2017-2022년)
    • 라틴아메리카의 점막하 주입제 판매 : 용도별(2017-2022년)
    • 중동 및 아프리카의 점막하 주입제 판매 : 용도별(2017-2022년)

제5장 북미의 점막하 주입제 : 국가별

  • 과거 시장 규모 : 국가별
  • 시장 규모 예측 : 국가별

제6장 유럽의 점막하 주입제 : 국가별

제7장 아시아태평양의 점막하 주입제 : 지역별

제8장 라틴아메리카의 점막하 주입제 : 국가별

제9장 중동 및 아프리카의 점막하 주입제 : 국가별

제10장 기업 개요 : 점막하 주입제사업의 주요 지표

  • SEIKAGAKU
  • OVESCO ENDOSCOPY
  • GI SUPPLY
  • COSMO PHARMACEUTICALS
  • BOSTON SCIENTIFIC
  • THE STANDARD
  • MICRO-TECH ENDOSCOPY
  • ENDOCLOT PLUS

제11장 업스트림(Upstream) 공정·기회·과제·리스크·영향요인 분석

  • 점막하 주입제의 주요 원재료
  • 제조 비용 구조
  • 점막하 주입제 산업 체인 분석
  • 점막하 주입제 시장 역학

제12장 마케팅 전략 분석, 유통업체

  • 판매 채널
  • 점막하 주입제 유통업체
  • 점막하 주입제 다운스트림(Downstream) 공정 고객

제13장 조사 결과와 결론

제14장 부록

LSH 22.07.28

LIST OF TABLES

  • Table 1. Global Submucosal Injection Agent Sales by Type: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Global Submucosal Injection Agent Sales by Type (2017-2022) & (K Units)
  • Table 3. Global Submucosal Injection Agent Sales Market Share in Volume by Type (2017-2022)
  • Table 4. Global Submucosal Injection Agent Sales by Type (2017-2022) & (US$ Million)
  • Table 5. Global Submucosal Injection Agent Sales Market Share in Value by Type (2017-2022)
  • Table 6. Global Submucosal Injection Agent Price by Type (2017-2022) & (US$/Unit)
  • Table 7. Global Submucosal Injection Agent Sales by Type (2023-2028) & (K Units)
  • Table 8. Global Submucosal Injection Agent Sales Market Share in Volume by Type (2023-2028)
  • Table 9. Global Submucosal Injection Agent Sales by Type (2023-2028) & (US$ Million)
  • Table 10. Global Submucosal Injection Agent Sales Market Share in Value by Type (2023-2028)
  • Table 11. Global Submucosal Injection Agent Price by Type (2023-2028) & (US$/Unit)
  • Table 12. North America Submucosal Injection Agent Sales by Type (2017-2022) & (K Units)
  • Table 13. Europe Submucosal Injection Agent Sales (K Units) by Type (2017-2022)
  • Table 14. Asia-Pacific Submucosal Injection Agent Sales (K Units) by Type (2017-2022)
  • Table 15. Latin America Submucosal Injection Agent Sales (K Units) by Type (2017-2022)
  • Table 16. Middle East and Africa Submucosal Injection Agent Sales (K Units) by Type (2017-2022)
  • Table 17. Global Submucosal Injection Agent Sales by Company (2020-2022) & (K Units)
  • Table 18. Global Submucosal Injection Agent Sales Share by Company (2020-2022)
  • Table 19. Global Submucosal Injection Agent Revenue by Company (2020-2022) & (US$ Million)
  • Table 20. Global Submucosal Injection Agent Revenue Share by Company (2020-2022)
  • Table 21. Global Market Submucosal Injection Agent Price by Company (2020-2022) & (US$/Unit)
  • Table 22. Global Submucosal Injection Agent Top Manufacturers Manufacturing Base Distribution and Sales Area
  • Table 23. Global Submucosal Injection Agent Manufacturers Market Concentration Ratio (CR5)
  • Table 24. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Submucosal Injection Agent as of 2021)
  • Table 25. Key Manufacturers Submucosal Injection Agent Product Type
  • Table 26. Global Submucosal Injection Agent Market Size Comparison by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 27. Global Submucosal Injection Agent Sales by Region (2017-2022) & (K Units)
  • Table 28. Global Submucosal Injection Agent Sales Market Share in Volume by Region (2017-2022)
  • Table 29. Global Submucosal Injection Agent Sales by Region (2017-2022) & (US$ Million)
  • Table 30. Global Submucosal Injection Agent Sales Market Share in Value by Region (2017-2022)
  • Table 31. Global Submucosal Injection Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) (2017-2022)
  • Table 32. Global Submucosal Injection Agent Sales by Region (2023-2028) & (K Units)
  • Table 33. Global Submucosal Injection Agent Sales Market Share in Volume by Region (2023-2028)
  • Table 34. Global Submucosal Injection Agent Sales by Region (2023-2028) & (US$ Million)
  • Table 35. Global Submucosal Injection Agent Sales Market Share in Value by Region (2023-2028)
  • Table 36. Global Submucosal Injection Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) (2023-2028)
  • Table 37. Global Submucosal Injection Agent Sales by Application: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 38. Global Submucosal Injection Agent Sales by Application (2017-2022) & (K Units)
  • Table 39. Global Submucosal Injection Agent Sales Market Share in Volume by Application (2017-2022)
  • Table 40. Global Submucosal Injection Agent Sales by Application (2017-2022) & (US$ Million)
  • Table 41. Global Submucosal Injection Agent Sales Market Share in Value by Application (2017-2022)
  • Table 42. Global Submucosal Injection Agent Price by Application (2017-2022) & (US$/Unit)
  • Table 43. Global Submucosal Injection Agent Sales by Application (2023-2028) & (K Units)
  • Table 44. Global Submucosal Injection Agent Sales Market Share in Volume by Application (2023-2028)
  • Table 45. Global Submucosal Injection Agent Sales by Application (2023-2028) & (US$ Million)
  • Table 46. Global Submucosal Injection Agent Sales Market Share in Value by Application (2023-2028)
  • Table 47. Global Submucosal Injection Agent Price by Application (2023-2028) & (US$/Unit)
  • Table 48. North America Submucosal Injection Agent Sales by Application (2017-2022) & (K Units)
  • Table 49. Europe Submucosal Injection Agent Sales (K Units) by Application (2017-2022)
  • Table 50. Asia-Pacific Submucosal Injection Agent Sales (K Units) by Application (2017-2022)
  • Table 51. Latin America Submucosal Injection Agent Sales (K Units) by Application (2017-2022)
  • Table 52. Middle East and Africa Submucosal Injection Agent Sales (K Units) by Application (2017-2022)
  • Table 53. North America Submucosal Injection Agent Sales by Country (2017-2022) & (K Units)
  • Table 54. North America Submucosal Injection Agent Sales Market Share in Volume by Country (2017-2022)
  • Table 55. North America Submucosal Injection Agent Sales by Country (2017-2022) & (US$ Million)
  • Table 56. North America Submucosal Injection Agent Sales Market Share in Value by Country (2017-2022)
  • Table 57. North America Submucosal Injection Agent Sales by Country (2023-2028) & (K Units)
  • Table 58. North America Submucosal Injection Agent Sales by Country (2023-2028) & (US$ Million)
  • Table 59. Europe Submucosal Injection Agent Sales by Country (2017-2022) & (K Units)
  • Table 60. Europe Submucosal Injection Agent Sales Market Share in Volume by Country (2017-2022)
  • Table 61. Europe Submucosal Injection Agent Sales by Country (2017-2022) & (US$ Million)
  • Table 62. Europe Submucosal Injection Agent Sales Market Share in Value by Country (2017-2022)
  • Table 63. Europe Submucosal Injection Agent Sales by Country (2023-2028) & (K Units)
  • Table 64. Europe Submucosal Injection Agent Sales by Country (2023-2028) & (US$ Million)
  • Table 65. Asia-Pacific Submucosal Injection Agent Sales by Region (2017-2022) & (K Units)
  • Table 66. Asia-Pacific Submucosal Injection Agent Sales Market Share in Volume by Region (2017-2022)
  • Table 67. Asia-Pacific Submucosal Injection Agent Sales by Region (2017-2022) & (US$ Million)
  • Table 68. Asia-Pacific Submucosal Injection Agent Sales Market Share in Value by Region (2017-2022)
  • Table 69. Asia-Pacific Submucosal Injection Agent Sales by Region (2023-2028) & (K Units)
  • Table 70. Asia-Pacific Submucosal Injection Agent Sales by Region (2023-2028) & (US$ Million)
  • Table 71. Latin America Submucosal Injection Agent Sales by Country (2017-2022) & (K Units)
  • Table 72. Latin America Submucosal Injection Agent Sales Market Share in Volume by Country (2017-2022)
  • Table 73. Latin America Submucosal Injection Agent Sales by Country (2017-2022) & (US$ Million)
  • Table 74. Latin America Submucosal Injection Agent Sales Market Share in Value by Country (2017-2022)
  • Table 75. Latin America Submucosal Injection Agent Sales by Country (2023-2028) & (K Units)
  • Table 76. Latin America Submucosal Injection Agent Sales by Country (2023-2028) & (US$ Million)
  • Table 77. Middle East and Africa Submucosal Injection Agent Sales by Country (2017-2022) & (K Units)
  • Table 78. Middle East and Africa Submucosal Injection Agent Sales Market Share in Volume by Country (2017-2022)
  • Table 79. Middle East and Africa Submucosal Injection Agent Sales by Country (2017-2022) & (US$ Million)
  • Table 80. Middle East and Africa Submucosal Injection Agent Sales Market Share in Value by Country (2017-2022)
  • Table 81. Middle East and Africa Submucosal Injection Agent Sales by Country (2023-2028) & (K Units)
  • Table 82. Middle East and Africa Submucosal Injection Agent Sales by Country (2023-2028) & (US$ Million)
  • Table 83. Seikagaku Corporation Information
  • Table 84. Seikagaku Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2022)
  • Table 85. Seikagaku Submucosal Injection Agent Product
  • Table 86. Ovesco Endoscopy Corporation Information
  • Table 87. Ovesco Endoscopy Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2022)
  • Table 88. Ovesco Endoscopy Submucosal Injection Agent Product
  • Table 89. GI Supply Corporation Information
  • Table 90. GI Supply Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2022)
  • Table 91. GI Supply Submucosal Injection Agent Product
  • Table 92. Cosmo Pharmaceuticals Corporation Information
  • Table 93. Cosmo Pharmaceuticals Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2022)
  • Table 94. Cosmo Pharmaceuticals Submucosal Injection Agent Product
  • Table 95. Boston Scientific Corporation Information
  • Table 96. Boston Scientific Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2022)
  • Table 97. Boston Scientific Submucosal Injection Agent Product
  • Table 98. The Standard Corporation Information
  • Table 99. The Standard Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2022)
  • Table 100. The Standard Submucosal Injection Agent Product
  • Table 101. Micro-Tech Endoscopy Corporation Information
  • Table 102. Micro-Tech Endoscopy Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2022)
  • Table 103. Micro-Tech Endoscopy Submucosal Injection Agent Product
  • Table 104. EndoClot Plus Corporation Information
  • Table 105. EndoClot Plus Submucosal Injection Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2022)
  • Table 106. EndoClot Plus Submucosal Injection Agent Product
  • Table 107. Raw Materials Key Suppliers Lists
  • Table 108. Submucosal Injection Agent Market Trends
  • Table 109. Submucosal Injection Agent Market Challenges
  • Table 110. Submucosal Injection Agent Distributors List
  • Table 111. Submucosal Injection Agent Downstream Customers
  • Table 112. Research Programs/Design for This Report
  • Table 113. Key Data Information from Secondary Sources
  • Table 114. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Submucosal Injection Agent Product Picture
  • Figure 2. Global Submucosal Injection Agent Market Size, 2017 VS 2021 VS 2028 (US$ Million)
  • Figure 3. Global Submucosal Injection Agent Market Size Status and Outlook (2017-2028) & (US$ Million)
  • Figure 4. Global Submucosal Injection Agent Sales Status and Outlook (2017-2028) & (K Units)
  • Figure 5. Product Picture of Syringe Type
  • Figure 6. Global Syringe Type Sales YoY Growth (2017-2028) & (K Units)
  • Figure 7. Product Picture of Ampoule Type
  • Figure 8. Global Ampoule Type Sales YoY Growth (2017-2028) & (K Units)
  • Figure 9. Global Submucosal Injection Agent Market Share by Type in 2021 & 2028
  • Figure 10. North America Submucosal Injection Agent Sales Market Share in Volume by Type in 2021
  • Figure 11. Europe Submucosal Injection Agent Sales Market Share in Volume by Type in 2021
  • Figure 12. Asia-Pacific Submucosal Injection Agent Sales Market Share in Volume by Type in 2021
  • Figure 13. Latin America Submucosal Injection Agent Sales Market Share in Volume by Type in 2021
  • Figure 14. Middle East and Africa Submucosal Injection Agent Sales Market Share in Volume by Type in 2021
  • Figure 15. The 3 Largest Manufacturers in the World: Market Share by Submucosal Injection Agent Revenue in 2021
  • Figure 16. The 5 Largest Manufacturers in the World: Market Share by Submucosal Injection Agent Revenue in 2021
  • Figure 17. Global Submucosal Injection Agent Market Share by Application in 2021
  • Figure 18. North America Submucosal Injection Agent Sales Market Share in Volume by Application in 2021
  • Figure 19. Europe Submucosal Injection Agent Sales Market Share in Volume by Application in 2021
  • Figure 20. Asia-Pacific Submucosal Injection Agent Sales Market Share in Volume by Application in 2021
  • Figure 21. Latin America Submucosal Injection Agent Sales Market Share in Volume by Application in 2021
  • Figure 22. Middle East and Africa Submucosal Injection Agent Sales Market Share in Volume by Application in 2021
  • Figure 23. Submucosal Injection Agent Manufacturing Cost Structure
  • Figure 24. Submucosal Injection Agent Industrial Chain Analysis
  • Figure 25. Channels of Distribution
  • Figure 26. Distributors Profiles
  • Figure 27. Bottom-up and Top-down Approaches for This Report
  • Figure 28. Data Triangulation
  • Figure 29. Key Executives Interviewed 74

Market Analysis and Insights:

Due to the COVID-19 pandemic, the global Submucosal Injection Agent market size was value at US$ 95.35 million in 2021 and is forecast to be a readjusted size of US$ 159.76 million by 2028 with a CAGR of 7.65% during the forecast period 2022-2028.

Scope and Market Size:

The global Submucosal Injection Agent market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Submucosal Injection Agent market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2017-2028.

By Company

  • Seikagaku
  • Ovesco Endoscopy
  • GI Supply
  • Cosmo Pharmaceuticals
  • Boston Scientific
  • The Standard
  • Micro-Tech Endoscopy
  • EndoClot Plus

Segment by Packaging Type

  • Syringe Type
  • Ampoule Type

Segment by Application

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Spain
    • Rest of Europe
  • Latin America
    • Brazil
    • Argentina
    • Colombia
    • Rest of Latin America
  • Middle East & Africa
    • Middle East
    • Africa

TABLE OF CONTENTS

1 SUBMUCOSAL INJECTION AGENT MARKET OVERVIEW

  • 1.1 SUBMUCOSAL INJECTION AGENT PRODUCT OVERVIEW
  • 1.2 SUBMUCOSAL INJECTION AGENT MARKET SEGMENT BY TYPE
    • 1.2.1 SYRINGE TYPE
    • 1.2.2 AMPOULE TYPE
  • 1.3 GLOBAL SUBMUCOSAL INJECTION AGENT MARKET SIZE BY TYPE
    • 1.3.1 GLOBAL SUBMUCOSAL INJECTION AGENT MARKET SIZE OVERVIEW BY TYPE (2017-2028)
    • 1.3.2 GLOBAL SUBMUCOSAL INJECTION AGENT HISTORIC MARKET SIZE REVIEW BY TYPE (2017-2022)
    • 1.3.3 GLOBAL SUBMUCOSAL INJECTION AGENT FORECASTED MARKET SIZE BY TYPE (2023-2028)
  • 1.4 KEY REGIONS MARKET SIZE SEGMENT BY TYPE
    • 1.4.1 NORTH AMERICA SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY TYPE (2017-2022)
    • 1.4.2 EUROPE SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY TYPE (2017-2022)
    • 1.4.3 ASIA-PACIFIC SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY TYPE (2017-2022)
    • 1.4.4 LATIN AMERICA SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY TYPE (2017-2022)
    • 1.4.5 MIDDLE EAST AND AFRICA SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY TYPE (2017-2022)

2 SUBMUCOSAL INJECTION AGENT MARKET COMPETITION BY COMPANY

  • 2.1 GLOBAL TOP PLAYERS BY SUBMUCOSAL INJECTION AGENT SALES (2020-2022)
  • 2.2 GLOBAL TOP PLAYERS BY SUBMUCOSAL INJECTION AGENT REVENUE (2020-2022)
  • 2.3 GLOBAL TOP PLAYERS BY SUBMUCOSAL INJECTION AGENT PRICE (2020-2022)
  • 2.4 GLOBAL TOP MANUFACTURERS SUBMUCOSAL INJECTION AGENT MANUFACTURING BASE DISTRIBUTION, SALES AREA
  • 2.5 SUBMUCOSAL INJECTION AGENT MARKET COMPETITIVE SITUATION AND TRENDS
    • 2.5.1 SUBMUCOSAL INJECTION AGENT MARKET CONCENTRATION RATE (2020-2022)
    • 2.5.2 GLOBAL 3 AND 5 LARGEST MANUFACTURERS BY SUBMUCOSAL INJECTION AGENT REVENUE IN 2021
  • 2.6 GLOBAL TOP MANUFACTURERS BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3) & (BASED ON THE REVENUE IN SUBMUCOSAL INJECTION AGENT AS OF 2021)
  • 2.7 KEY MANUFACTURERS SUBMUCOSAL INJECTION AGENT PRODUCT OFFERED

3 SUBMUCOSAL INJECTION AGENT STATUS AND OUTLOOK BY REGION

  • 3.1 GLOBAL SUBMUCOSAL INJECTION AGENT MARKET SIZE AND CAGR BY REGION: 2017 VS 2021 VS 2028
  • 3.2 GLOBAL SUBMUCOSAL INJECTION AGENT HISTORIC MARKET SIZE BY REGION
    • 3.2.1 GLOBAL SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY REGION (2017-2022)
    • 3.2.2 GLOBAL SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY REGION (2017-2022)
    • 3.2.3 GLOBAL SUBMUCOSAL INJECTION AGENT SALES (VOLUME & VALUE), PRICE (2017-2022)
  • 3.3 GLOBAL SUBMUCOSAL INJECTION AGENT FORECASTED MARKET SIZE BY REGION
    • 3.3.1 GLOBAL SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY REGION (2023-2028)
    • 3.3.2 GLOBAL SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY REGION (2023-2028)
    • 3.3.3 GLOBAL SUBMUCOSAL INJECTION AGENT SALES (VOLUME & VALUE), PRICE (2023-2028)

4 SUBMUCOSAL INJECTION AGENT BY APPLICATION

  • 4.1 GLOBAL SUBMUCOSAL INJECTION AGENT MARKET SIZE BY APPLICATION
    • 4.1.1 GLOBAL SUBMUCOSAL INJECTION AGENT MARKET SIZE OVERVIEW BY APPLICATION (2017-2028)
    • 4.1.2 GLOBAL SUBMUCOSAL INJECTION AGENT HISTORIC MARKET SIZE REVIEW BY APPLICATION (2017-2022)
    • 4.1.3 GLOBAL SUBMUCOSAL INJECTION AGENT FORECASTED MARKET SIZE BY APPLICATION (2023-2028)
  • 4.2 KEY REGIONS MARKET SIZE SEGMENT BY APPLICATION
    • 4.2.1 NORTH AMERICA SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY APPLICATION (2017-2022)
    • 4.2.2 EUROPE SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY APPLICATION (2017-2022)
    • 4.2.3 ASIA-PACIFIC SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY APPLICATION (2017-2022)
    • 4.2.4 LATIN AMERICA SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY APPLICATION (2017-2022)
    • 4.2.5 MIDDLE EAST AND AFRICA SUBMUCOSAL INJECTION AGENT SALES BREAKDOWN BY APPLICATION (2017-2022)

5 NORTH AMERICA SUBMUCOSAL INJECTION AGENT BY COUNTRY

  • 5.1 NORTH AMERICA SUBMUCOSAL INJECTION AGENT HISTORIC MARKET SIZE BY COUNTRY
    • 5.1.1 NORTH AMERICA SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY COUNTRY (2017-2022)
    • 5.1.2 NORTH AMERICA SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY COUNTRY (2017-2022)
  • 5.2 NORTH AMERICA SUBMUCOSAL INJECTION AGENT FORECASTED MARKET SIZE BY COUNTRY
    • 5.2.1 NORTH AMERICA SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY COUNTRY (2023-2028)
    • 5.2.2 NORTH AMERICA SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY COUNTRY (2023-2028)

6 EUROPE SUBMUCOSAL INJECTION AGENT BY COUNTRY

  • 6.1 EUROPE SUBMUCOSAL INJECTION AGENT HISTORIC MARKET SIZE BY COUNTRY
    • 6.1.1 EUROPE SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY COUNTRY (2017-2022)
    • 6.1.2 EUROPE SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY COUNTRY (2017-2022)
  • 6.2 EUROPE SUBMUCOSAL INJECTION AGENT FORECASTED MARKET SIZE BY COUNTRY
    • 6.2.1 EUROPE SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY COUNTRY (2023-2028)
    • 6.2.2 EUROPE SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY COUNTRY (2023-2028)

7 ASIA-PACIFIC SUBMUCOSAL INJECTION AGENT BY REGION

  • 7.1 ASIA-PACIFIC SUBMUCOSAL INJECTION AGENT HISTORIC MARKET SIZE BY REGION
    • 7.1.1 ASIA-PACIFIC SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY REGION (2017-2022)
    • 7.1.2 ASIA-PACIFIC SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY REGION (2017-2022)
  • 7.2 ASIA-PACIFIC SUBMUCOSAL INJECTION AGENT FORECASTED MARKET SIZE BY REGION
    • 7.2.1 ASIA-PACIFIC SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY REGION (2023-2028)
    • 7.2.2 ASIA-PACIFIC SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY REGION (2023-2028)

8 LATIN AMERICA SUBMUCOSAL INJECTION AGENT BY COUNTRY

  • 8.1 LATIN AMERICA SUBMUCOSAL INJECTION AGENT HISTORIC MARKET SIZE BY COUNTRY
    • 8.1.1 LATIN AMERICA SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY COUNTRY (2017-2022)
    • 8.1.2 LATIN AMERICA SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY COUNTRY (2017-2022)
  • 8.2 LATIN AMERICA SUBMUCOSAL INJECTION AGENT FORECASTED MARKET SIZE BY COUNTRY
    • 8.2.1 LATIN AMERICA SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY COUNTRY (2023-2028)
    • 8.2.2 LATIN AMERICA SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY COUNTRY (2023-2028)

9 MIDDLE EAST AND AFRICA SUBMUCOSAL INJECTION AGENT BY COUNTRY

  • 9.1 MIDDLE EAST AND AFRICA SUBMUCOSAL INJECTION AGENT HISTORIC MARKET SIZE BY COUNTRY
    • 9.1.1 MIDDLE EAST AND AFRICA SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY COUNTRY (2017-2022)
    • 9.1.2 MIDDLE EAST AND AFRICA SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY COUNTRY (2017-2022)
  • 9.2 MIDDLE EAST AND AFRICA SUBMUCOSAL INJECTION AGENT FORECASTED MARKET SIZE BY COUNTRY
    • 9.2.1 MIDDLE EAST AND AFRICA SUBMUCOSAL INJECTION AGENT SALES IN VOLUME BY COUNTRY (2023-2028)
    • 9.2.2 MIDDLE EAST AND AFRICA SUBMUCOSAL INJECTION AGENT SALES IN VALUE BY COUNTRY (2023-2028)

10 COMPANY PROFILES AND KEY FIGURES IN SUBMUCOSAL INJECTION AGENT BUSINESS

  • 10.1 SEIKAGAKU
    • 10.1.1 SEIKAGAKU CORPORATION INFORMATION
    • 10.1.2 SEIKAGAKU INTRODUCTION AND BUSINESS OVERVIEW
    • 10.1.3 SEIKAGAKU SUBMUCOSAL INJECTION AGENT SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 10.1.4 SEIKAGAKU SUBMUCOSAL INJECTION AGENT PRODUCTS OFFERED
  • 10.2 OVESCO ENDOSCOPY
    • 10.2.1 OVESCO ENDOSCOPY CORPORATION INFORMATION
    • 10.2.2 OVESCO ENDOSCOPY INTRODUCTION AND BUSINESS OVERVIEW
    • 10.2.3 OVESCO ENDOSCOPY SUBMUCOSAL INJECTION AGENT SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 10.2.4 OVESCO ENDOSCOPY SUBMUCOSAL INJECTION AGENT PRODUCTS OFFERED
  • 10.3 GI SUPPLY
    • 10.3.1 GI SUPPLY CORPORATION INFORMATION
    • 10.3.2 GI SUPPLY INTRODUCTION AND BUSINESS OVERVIEW
    • 10.3.3 GI SUPPLY SUBMUCOSAL INJECTION AGENT SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 10.3.4 GI SUPPLY SUBMUCOSAL INJECTION AGENT PRODUCTS OFFERED
  • 10.4 COSMO PHARMACEUTICALS
    • 10.4.1 COSMO PHARMACEUTICALS CORPORATION INFORMATION
    • 10.4.2 COSMO PHARMACEUTICALS INTRODUCTION AND BUSINESS OVERVIEW
    • 10.4.3 COSMO PHARMACEUTICALS SUBMUCOSAL INJECTION AGENT SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 10.4.4 COSMO PHARMACEUTICALS SUBMUCOSAL INJECTION AGENT PRODUCTS OFFERED
  • 10.5 BOSTON SCIENTIFIC
    • 10.5.1 BOSTON SCIENTIFIC CORPORATION INFORMATION
    • 10.5.2 BOSTON SCIENTIFIC INTRODUCTION AND BUSINESS OVERVIEW
    • 10.5.3 BOSTON SCIENTIFIC SUBMUCOSAL INJECTION AGENT SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 10.5.4 BOSTON SCIENTIFIC SUBMUCOSAL INJECTION AGENT PRODUCTS OFFERED
  • 10.6 THE STANDARD
    • 10.6.1 THE STANDARD CORPORATION INFORMATION
    • 10.6.2 THE STANDARD INTRODUCTION AND BUSINESS OVERVIEW
    • 10.6.3 THE STANDARD SUBMUCOSAL INJECTION AGENT SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 10.6.4 THE STANDARD SUBMUCOSAL INJECTION AGENT PRODUCTS OFFERED
  • 10.7 MICRO-TECH ENDOSCOPY
    • 10.7.1 MICRO-TECH ENDOSCOPY CORPORATION INFORMATION
    • 10.7.2 MICRO-TECH ENDOSCOPY INTRODUCTION AND BUSINESS OVERVIEW
    • 10.7.3 MICRO-TECH ENDOSCOPY SUBMUCOSAL INJECTION AGENT SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 10.7.4 MICRO-TECH ENDOSCOPY SUBMUCOSAL INJECTION AGENT PRODUCTS OFFERED
  • 10.8 ENDOCLOT PLUS
    • 10.8.1 ENDOCLOT PLUS CORPORATION INFORMATION
    • 10.8.2 ENDOCLOT PLUS INTRODUCTION AND BUSINESS OVERVIEW
    • 10.8.3 ENDOCLOT PLUS SUBMUCOSAL INJECTION AGENT SALES, REVENUE AND GROSS MARGIN (2020-2022)
    • 10.8.4 ENDOCLOT PLUS SUBMUCOSAL INJECTION AGENT PRODUCTS OFFERED

11 UPSTREAM, OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS

  • 11.1 SUBMUCOSAL INJECTION AGENT KEY RAW MATERIALS
    • 11.1.1 KEY RAW MATERIALS
    • 11.1.2 RAW MATERIALS KEY SUPPLIERS
  • 11.2 MANUFACTURING COST STRUCTURE
    • 11.2.1 RAW MATERIALS
    • 11.2.2 LABOR COST
    • 11.2.3 MANUFACTURING EXPENSES
  • 11.3 SUBMUCOSAL INJECTION AGENT INDUSTRIAL CHAIN ANALYSIS
  • 11.4 SUBMUCOSAL INJECTION AGENT MARKET DYNAMICS
    • 11.4.1 SUBMUCOSAL INJECTION AGENT INDUSTRY TRENDS
    • 11.4.2 SUBMUCOSAL INJECTION AGENT MARKET DRIVERS
    • 11.4.3 SUBMUCOSAL INJECTION AGENT MARKET CHALLENGES

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS

  • 12.1 SALES CHANNEL
  • 12.2 SUBMUCOSAL INJECTION AGENT DISTRIBUTORS
  • 12.3 SUBMUCOSAL INJECTION AGENT DOWNSTREAM CUSTOMERS

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

  • 14.1 RESEARCH METHODOLOGY
    • 14.1.1 METHODOLOGY/RESEARCH APPROACH
    • 14.1.2 DATA SOURCE
  • 14.2 AUTHOR DETAILS
  • 14.3 DISCLAIMER
Back to Top
전화 문의
F A Q